SecBot SecBot
SECBOTREPLAY Home › Report › REGN

REGN · Director Kathryn Guarini filed a Form 144 notice of intent to sell 400…

REGENERON PHARMACEUTICALS, INC. · 144 filed Oct 30, 2026 at 16:15 ET

At the news

NEUTRALIMPACT 2/10

144 filed Oct 30, 2026 at 16:15 ET

Director Kathryn Guarini filed a Form 144 notice of intent to sell 400 shares of Regeneron common stock, valued at approximately $360,000 based on the filing price. The shares were acquired through option exercise and the sale is a routine, small disposition relative to the director's total holdings and the company's $83.7B market cap.

  • Director Kathryn Guarini filed Form 144 to sell 400 shares of Regeneron common stock.
  • Estimated value of the proposed sale is $360,000.
  • Shares were acquired via exercise of stock options on October 30, 2026.
  • The sale is a small fraction of the director's total holdings (101,630,713 shares outstanding).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access